Stocktoria
Alcon Inc. ALC.SW
CH · SIX Swiss Exchange · XSWX · stock · Healthcare · website
Alcon Inc. financials (annual, from 10-K)
Bars are annual figures from 2022 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | $10.4B | $9.9B | $9.5B | $8.7B |
| Gross profit | $5.7B | $5.5B | $5.2B | $4.7B |
| R&D expense | $990.0M | $876.0M | $828.0M | $702.0M |
| SG&A expense | $3.4B | $3.2B | $3.2B | $3.1B |
| Operating income | $1.4B | $1.4B | $1.0B | $672.0M |
| Interest expense | $204.0M | $192.0M | $189.0M | $134.0M |
| Income tax | $180.0M | $238.0M | -$142.0M | $128.0M |
| Net income | $980.0M | $1.0B | $974.0M | $335.0M |
| EPS (diluted) | $1.98 | $2.05 | $1.96 | $0.68 |
| Operating cash flow | $2.3B | $2.1B | $1.4B | $1.2B |
| Free cash flow | $1.6B | $1.4B | $537.0M | $472.0M |
| Cash & equivalents | — | $1.7B | $1.1B | $980.0M |
| Inventory | $2.4B | $2.3B | $2.3B | $2.1B |
| Total assets | $31.6B | $30.3B | $29.6B | $29.2B |
| Total liabilities | $31.6B | $30.3B | $9.0B | $9.5B |
| Shareholders' equity | $22.0B | $21.5B | $20.6B | $19.7B |
Growth · year-over-year · Revenue CAGR 6.1%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue growth | +4.9% | +4.8% | +8.5% | — |
| Net income growth | -3.7% | +4.5% | +190.7% | — |
| EPS growth | -3.4% | +4.6% | +188.2% | — |
| Free cash flow growth | +14.3% | +162.0% | +13.8% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: company filings via Yahoo Finance · CH · as of 2025-12-31. Figures in CHF; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.